Brett Monia | Chief Executive Officer |
Beth Hougen | Chief Financial Officer |
Richard Geary | Executive Vice President of Development |
Eric Swayze | Executive Vice President of Research |
Eugene Schneider | Chief Clinical Development Officer |
Onaiza Cadoret | Chief Global Product Strategy & Operations Officer |
Yanan Zhu | Wells Fargo |
Jessica Fye | JPMorgan |
Do Kim | Piper Sandler |
Gena Wang | Barclays |
I-Eh Jen | Laidlaw & Co. |
Luca Issi | RBC |
Myles Minter | William Blair |
Yaron Werber | Cowen |
Joseph Stringer | Needham & Co. |
Gary Nachman | BMO Capital Markets |
Good morning, and welcome to the Ionis Pharmaceuticals Second Quarter 2022 Financial Results Conference Call.
As a reminder, this call is being recorded. At this time, I would like to turn the call over to Julie Tepper [ph], Investor Relations, to lead off the call. Please begin.
Thank you, Betsy.